Who owns CVS Health (CVS)? Superinvestor holders
22 superinvestors of the 157 tracked here hold CVS Health (CVS) in their latest 13F filing, with $9.7B between them. Larry Robbins gives it the most weight: 9.97% of the reported portfolio.
Key facts
- Superinvestors holding it
- 22 of 157
- Biggest holder
- Dodge & Cox team, $3.9B
- Largest weight
- Larry Robbins, 9.97%of their portfolio
- Combined value
- $9.7B
- Bought last quarter
- 7
- Sold last quarter
- 14
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Larry RobbinsGlenview Capital Management | 9.97% | $499.1M | 4.82M | ▼ Reduced 41% | −3.37M | Q2 2026 |
| 2 | Prem WatsaFairfax Financial | 8.78% | $232.4M | 2.71M | No change | 0 | Q3 2026 |
| 3 | Christopher DavisDavis Advisors | 4.40% | $1B | 11.9M | ▲ Added 0.3% | +29.67K | Q3 2026 |
| 4 | Samantha McLemorePatient Capital Management | 2.79% | $83.1M | 969.97K | ▼ Reduced 21% | −265.5K | Q3 2026 |
| 5 | Richard PzenaPzena Investment Management | 2.59% | $882.3M | 10.3M | ▼ Reduced 13% | −1.47M | Q3 2026 |
| 6 | Dodge & Cox teamDodge & Cox | 2.12% | $3.9B | 46.04M | ▼ Reduced 7.9% | −3.97M | Q3 2026 |
| 7 | Andreas HalvorsenViking Global Investors | 1.08% | $379M | 3.66M | New | +3.66M | Q2 2026 |
| 8 | Charles Brandes (founder)Brandes Investment Partners | 0.85% | $124.3M | 1.45M | ▼ Reduced 13% | −224.37K | Q3 2026 |
| 9 | Mark BoyarBoyar Asset Management | 0.85% | $1.4M | 15.92K | ▼ Reduced 0.8% | −135 | Q3 2026 |
| 10 | John RogersAriel Investments | 0.74% | $70.7M | 824.86K | ▲ Added 13% | +94.77K | Q3 2026 |
| 11 | Brandon HaleyHolocene Advisors | 0.71% | $310.5M | 3M | ▼ Reduced 33% | −1.48M | Q2 2026 |
| 12 | Josef LakonishokLSV Asset Management | 0.71% | $381.8M | 4.46M | ▼ Reduced 3.9% | −179.86K | Q3 2026 |
| 13 | Rajiv JainGQG Partners | 0.45% | $241.2M | 2.81M | ▼ Reduced 65% | −5.14M | Q3 2026 |
| 14 | Jim Simons (1938–2024)Renaissance Technologies | 0.32% | $233.4M | 2.72M | ▲ Added 518% | +2.28M | Q3 2026 |
| 15 | Steve CohenPoint72 Asset Management | 0.31% | $202.9M | 1.96M | New | +1.96M | Q2 2026 |
| 16 | Ken GriffinCitadel Advisors | 0.29% | $497.9M | 4.81M | ▼ Reduced 11% | −615.54K | Q2 2026 |
| 17 | Ray Dalio (founder)Bridgewater Associates | 0.19% | $45.6M | 440.97K | ▼ Reduced 29% | −177.42K | Q2 2026 |
| 18 | Paul Tudor JonesTudor Investment Corp | 0.16% | $38.3M | 370K | ▼ Reduced 46% | −311.78K | Q2 2026 |
| 19 | Israel EnglanderMillennium Management | 0.15% | $224M | 2.16M | ▲ Added more than 10× | +1.97M | Q2 2026 |
| 20 | Primecap teamPrimecap Management | 0.13% | $204M | 2.38M | ▼ Reduced 0.2% | −5.25K | Q3 2026 |
| 21 | Jeremy Grantham (co-founder)GMO (Grantham, Mayo, Van Otterloo) | 0.10% | $46.8M | 545.74K | ▲ Added 0.9% | +4.6K | Q3 2026 |
| 22 | Bill NygrenHarris Associates (Oakmark) | 0.05% | $34.7M | 335.82K | ▼ Reduced 32% | −158.32K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 13 | 87.13M | $7.5B | 4 | 8 |
| Q2 2026 | 157 | 21 | 117.11M | $12.1B | 7 | 15 |
| Q1 2026 | 157 | 20 | 112.21M | $8.1B | 8 | 15 |
| Q4 2025 | 157 | 24 | 131.85M | $10.5B | 9 | 15 |
| Q3 2025 | 157 | 22 | 140.4M | $10.6B | 6 | 13 |
| Q2 2025 | 157 | 21 | 146.14M | $10.1B | 10 | 11 |
| Q1 2025 | 156 | 21 | 160.84M | $10.9B | 12 | 9 |
| Q4 2024 | 156 | 20 | 151.44M | $6.8B | 10 | 13 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Dodge & Cox team | 46.04M | 50.01M | 51.78M | 62.51M | 73.18M | 73.29M | 73.46M | 70.11M |
| Christopher Davis | 11.9M | 11.87M | 12.24M | 12.76M | 11.4M | 11.59M | 11.55M | 11.39M |
| Richard Pzena | 10.3M | 11.77M | 13.77M | 15.58M | 15.84M | 16.75M | 17.68M | 19.61M |
| Josef Lakonishok | 4.46M | 4.64M | 4.5M | 4.54M | 4.62M | 4.76M | 5.05M | 5.4M |
| Rajiv Jain | 2.81M | 7.96M | 31.52K | 31.52K | — | — | — | — |
| Jim Simons (1938–2024) | 2.72M | — | — | — | — | — | — | — |
| Prem Watsa | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M |
| Primecap team | 2.38M | 2.39M | 2.4M | 2.41M | 2.67M | 2.93M | 2.92M | 3M |
| Charles Brandes (founder) | 1.45M | 1.67M | 1.97M | 1.85M | 1.8M | 1.72M | 1.7M | 1.56M |
| Samantha McLemore | 969.97K | 1.24M | 1.36M | 1.23M | 1.24M | 1.24M | 1.33M | 1.3M |
| John Rogers | 824.86K | 730.11K | 702.15K | 825.09K | 989.65K | 1.16M | 1.02M | 928.63K |
| Jeremy Grantham (co-founder) | 545.74K | 541.12K | 634.85K | 721.12K | 760.95K | 852.23K | 941.37K | 775.8K |
| Mark Boyar | 15.92K | 16.05K | 15.76K | 17.16K | 17.8K | 18.78K | 18.43K | 20.67K |
| Larry Robbins | · | 4.82M | 8.2M | 8.2M | 8.2M | 8.2M | 11.95M | 11.95M |
| Ken Griffin | · | 4.81M | 5.43M | 3.6M | 3.22M | 8.18M | 6.26M | 6.37M |
| Andreas Halvorsen | · | 3.66M | — | — | — | — | — | — |
| Brandon Haley | · | 3M | 4.48M | 3.97M | 1.67M | 2.37M | 5.93M | 2.64M |
| Israel Englander | · | 2.16M | — | 3.46M | 5.38M | 4.07M | 3.73M | 4.19M |
| Steve Cohen | · | 1.96M | — | 2.09M | — | — | — | — |
| Ray Dalio (founder) | · | 440.97K | 618.43K | 1.04M | 1.19M | 836.59K | — | — |
| Paul Tudor Jones | · | 370K | 681.81K | — | — | — | — | 977.7K |
| Bill Nygren | · | 335.82K | 494.13K | 525.05K | 548.57K | 844.05K | 6M | 5.71M |
| Doug Silverman | — | — | 175K | — | — | — | — | — |
| Tweedy, Browne team | — | — | 19.13K | 12.09K | 10.36K | 5.06K | — | — |
| Scott Ferguson | — | — | — | 2.59M | 3.15M | 3.02M | 3.13M | 625K |
| Karthik Sarma | — | — | — | 612.78K | 1.22M | 1.22M | 1.22M | — |
| Louis Bacon | — | — | — | 350K | 325K | 375K | 140K | 476.57K |
| Robert Pitts | · | — | — | 226K | — | — | — | — |
| Jeffrey Altman | — | — | — | — | 259.06K | — | 436.75K | — |
| Cliff Asness | · | — | — | — | — | — | 3.69M | — |
| John Overdeck and David Siegel (founders) | — | — | — | — | — | — | — | 1.71M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own CVS?
In their latest 13F filings: Larry Robbins (9.97% of the portfolio, $499.1M), Prem Watsa (8.78% of the portfolio, $232.4M), Christopher Davis (4.40% of the portfolio, $1B), Samantha McLemore (2.79% of the portfolio, $83.1M), Richard Pzena (2.59% of the portfolio, $882.3M), Dodge & Cox team (2.12% of the portfolio, $3.9B), Andreas Halvorsen (1.08% of the portfolio, $379M), Charles Brandes (founder) (0.85% of the portfolio, $124.3M), and 14 more.
Who bought CVS last quarter?
Christopher Davis (added 0.3%), Andreas Halvorsen (new position), John Rogers (added 13%), Jim Simons (1938–2024) (added 518%), Steve Cohen (new position), Israel Englander (added 1,014%), Jeremy Grantham (co-founder) (added 0.9%). “Last quarter” is each investor's latest reported quarter.
Who sold CVS last quarter?
Reduced: Larry Robbins (41% fewer shares), Samantha McLemore (21% fewer shares), Richard Pzena (13% fewer shares), Dodge & Cox team (7.9% fewer shares), Charles Brandes (founder) (13% fewer shares), Mark Boyar (0.8% fewer shares), Brandon Haley (33% fewer shares), Josef Lakonishok (3.9% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns CVS Health (CVS)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/CVS/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to CVS by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.